Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pred-Gati-Brom
- Development stage
- Phase 4
- Lead developer
- ImprimisRx
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
**Pred-Gati-Brom** is a compounded ophthalmic fixed-dose suspension containing prednisolone acetate 1%, gatifloxacin 0.5%, and bromfenac 0.075%. It is supplied by ImprimisRx for topical ocular use, including prophylaxis and management of postoperative ocular inflammation and infection following cataract surgery. Prednisolone acetate activates the glucocorticoid receptor to suppress inflammatory signaling; gatifloxacin inhibits bacterial DNA gyrase and topoisomerase IV; and bromfenac inhibits cyclooxygenase enzymes to reduce prostaglandin-mediated inflammation. Pred-Gati-Brom is a prescription compounded medication and is not an FDA-approved drug product. ([imprimisrx.com](https://www.imprimisrx.com/assets/Ophth_Catalog_D.pdf))
- Brand names
- Pred-Gati-Brom
- Other names
- prednisolone acetate + gatifloxacin + bromfenacPrednisolone Acetate-Gatifloxacin-Bromfenac
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)GR (Glucocorticoid receptor)Topo IV (Bacterial Topoisomerase IV)DNA gyrase
Beyond the preview
Go deeper on Pred-Gati-Brom.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pred-Gati-Brom.